We are live on
!
Find out more
AAP
Aristotle Atlantic Partners Portfolio holdings
AUM
$2.14B
1-Year Est. Return
37.01%
This Fund
S&P 500
This Quarter
Est. Return
+5.83%
1 Year Est. Return
+37.01%
3 Year Est. Return
+123.74%
5 Year Est. Return
+154.13%
10 Year Est. Return
–
AUM
$288M
AUM Growth
+$11.3M
(+4.1%)
Cap. Flow
-$1.59M
Cap. Flow
% of AUM
-0.55%
Top 10 Holdings %
Top 10 Hldgs %
61.3%
Holding
95
New
4
Increased
57
Reduced
8
Closed
12
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bio-Techne
TECH
|
+$2.61M |
| 2 |
Microsoft
MSFT
|
+$1.81M |
| 3 |
Global Payments
GPN
|
+$1.78M |
| 4 |
SAGE
Sage Therapeutics
SAGE
|
+$1.37M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$951K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MON
Monsanto Co
MON
|
+$7.03M |
| 2 |
SHPG
Shire pic
SHPG
|
+$2.89M |
| 3 |
Gilead Sciences
GILD
|
+$2.4M |
| 4 |
EVHC
Envision Healthcare Holdings Inc
EVHC
|
+$1.54M |
| 5 |
Murphy Oil
MUR
|
+$1.51M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 33.61% |
| 2 | Energy | 17.8% |
| 3 | Industrials | 17.78% |
| 4 | Technology | 10.38% |
| 5 | Financials | 6.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Trane Technologies
TT
$103B
| $318K | 0.11% |
3,546
+780
| +28% | +$68.5K |
|
77
Stanley Black & Decker
SWK
$13.6B
| $274K | 0.1% |
2,066
+456
| +28% | +$65.6K |
|
|
FLOW
78
DELISTED
SPX FLOW, Inc.
FLOW
| $264K | 0.09% |
6,042
-4,229
| -41% | -$193K |
|
79
Meta Platforms (Facebook)
META
$1.64T
| $262K | 0.09% |
1,350
| – | – |
|
80
Aramark
ARMK
$14.8B
| $247K | 0.09% |
9,224
+1,841
| +25% | +$50.9K |
|
81
Palo Alto Networks
PANW
$284B
| $226K | 0.08% |
6,600
| – | – |
|
82
SPX Corp
SPXC
$10.7B
| $211K | 0.07% |
+6,042
| New | +$205K |
|
83
Energy Recovery
ERII
$437M
| $121K | 0.04% |
15,000
| – | – |
|
84
Albemarle
ALB
$13.9B
| – | – |
-2,300
| Closed | -$213K |
|
85
Bristol-Myers Squibb
BMY
$123B
| – | – |
-3,600
| Closed | -$228K |
|
86
Casey's General Stores
CASY
$32.1B
| – | – |
-2,461
| Closed | -$270K |
|
87
Ciena
CIEN
$53.6B
| – | – |
-16,676
| Closed | -$432K |
|
88
Dover
DOV
$28.2B
| – | – |
-2,600
| Closed | -$206K |
|
89
GE Aerospace
GE
$354B
| – | – |
-5,851
| Closed | -$378K |
|
90
Oracle
ORCL
$350B
| – | – |
-9,022
| Closed | -$413K |
|
91
Philip Morris
PM
$300B
| – | – |
-2,400
| Closed | -$239K |
|
|
SRCL
92
DELISTED
Stericycle Inc
SRCL
| – | – |
-25,000
| Closed | -$1.46M |
|
|
EVHC
93
DELISTED
Envision Healthcare Holdings Inc
EVHC
| – | – |
-39,982
| Closed | -$1.54M |
|
|
MON
94
DELISTED
Monsanto Co
MON
| – | – |
-60,200
| Closed | -$7.03M |
|
|
SHPG
95
DELISTED
Shire pic
SHPG
| – | – |
-19,322
| Closed | -$2.89M |
|
Similar funds
SC
EF
PI
NAAA
GA
GHA
BCM
MA
Aristotle Atlantic Partners's Q2 2018 Portfolio in Review
As of Q2 2018, Aristotle Atlantic Partners held 95 positions worth $288M, up 4.1% from $277M the previous quarter. Its ten largest holdings account for 61% of the portfolio.
Aristotle Atlantic Partners's Q2 2018 filing shows 4 new, 57 increased, 8 reduced and 12 closed positions. Its largest new stake was Sage Therapeutics: 8,700 shares worth $1.36M. The largest sale was Monsanto Co, an estimated $7.03M.
By sector, the portfolio is most concentrated in Healthcare at 34% of assets, down from 34% a quarter earlier, followed by Energy and Industrials.
- Aristotle Atlantic Partners's largest Q2 2018 buy was Sage Therapeutics: 8,700 shares worth $1.36M.
- Aristotle Atlantic Partners added most to Bio-Techne in Q2 2018, an estimated $2.61M increase.
- Aristotle Atlantic Partners's biggest Q2 2018 reduction was Gilead Sciences, cutting an estimated $2.4M.
- Aristotle Atlantic Partners fully exited Monsanto Co in Q2 2018, selling an estimated $7.03M.
- Aristotle Atlantic Partners's ten largest holdings make up 61% of its $288M portfolio in Q2 2018.
- Aristotle Atlantic Partners opened 4 new positions and closed 12 in Q2 2018.
- Aristotle Atlantic Partners's portfolio value rose 4.1% quarter-over-quarter to $288M.
Based on Aristotle Atlantic Partners's 13F filing for Q2 2018, filed 14 Aug 2018.